Fidaxomicin
Fidaxomicin is a macrolide antibiotic used primarily for the treatment of Clostridioides difficile infection (CDI), a condition that can cause severe diarrhea and colitis. It is known for its narrow spectrum of activity, which targets Clostridioides difficile with minimal impact on the normal gut flora.
Mechanism of Action
Fidaxomicin works by inhibiting the bacterial enzyme RNA polymerase, which is essential for transcription and subsequent protein synthesis. This inhibition leads to the death of the bacteria, effectively treating the infection.
Pharmacokinetics
Fidaxomicin is minimally absorbed from the gastrointestinal tract, which allows it to act locally in the intestines. This property is beneficial as it reduces the risk of systemic side effects and maintains a high concentration of the drug at the site of infection.
Clinical Use
Fidaxomicin is specifically indicated for the treatment of Clostridioides difficile infection in adults. It is often reserved for cases where other treatments, such as metronidazole or vancomycin, have failed or are not suitable.
Side Effects
Common side effects of fidaxomicin include nausea, vomiting, and abdominal pain. Serious side effects are rare but can include hypersensitivity reactions.
Comparison with Other Treatments
Compared to other antibiotics like metronidazole and vancomycin, fidaxomicin has a lower recurrence rate of Clostridioides difficile infection. This makes it a valuable option in the management of recurrent CDI.
History
Fidaxomicin was approved by the Food and Drug Administration (FDA) in 2011 for the treatment of Clostridioides difficile infection. It was developed by Optimer Pharmaceuticals and is marketed under the brand name Dificid.
Research and Development
Ongoing research is exploring the use of fidaxomicin in pediatric populations and its potential effectiveness against other bacterial infections.
See Also
References
External Links
-
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
